What does met Apotheken do?

met Apotheken is a pharmacy in Bree. Private Limited, started on 18 February 2022, 1 establishment.

What is the address of met Apotheken?

The registered office of met Apotheken is located at Witte Torenwal 41, 3960 Bree.

Is met Apotheken still active?

Yes. According to the CBE (29 October 2026) met Apotheken is active, legal situation “Normale toestand”, started on 18 February 2022.

Is met Apotheken registered on Peppol?

Yes, met Apotheken is registered on the Peppol network with ID 0208:0782370920.

What is the enterprise number of met Apotheken?

The enterprise number of met Apotheken is BE0782370920.

When was met Apotheken founded?

met Apotheken was founded on 18 February 2022.

Who are the directors of met Apotheken?

According to the 2025 annual accounts, the directors of met Apotheken are: Van Dijck-Voets Management BV, A. Jans Pharma BV, Maan Invest BV, Dreesen BV.

Is met Apotheken a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 18 February 2022; 4 annual accounts filed, latest fiscal year 2025; 4 directors known from the annual account.

How much profit did met Apotheken make in 2025?

met Apotheken posted a profit after taxes of € 399,050 in financial year 2025.

What is the revenue of met Apotheken?

As a small company, met Apotheken is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 434,700.

How much does an employee at met Apotheken earn?

The average wage cost per full-time employee at met Apotheken was € 72,000 in 2025: staff costs of € 187,125 for 2.6 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does met Apotheken have?

According to the 2025 annual accounts, met Apotheken has 2.6 full-time equivalents (FTE).

met Apotheken (Private Limited) - Bree - BE0782370920

Dossier met Apotheken, printed on 29 October 2026 from databakkes.be/en/0782370920/met-apotheken. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

met Apotheken from Bree, company number BE0782370920, closed financial year 2025 with a result of € 399,050 after tax. For that financial year met Apotheken recorded a gross margin of € 434,700 and equity of € 1.3 million. Compared with financial year 2024, the result moved from € 374,598 to € 399,050. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 22, 2026.

What it is worth Growing

€ 1.3 million

▲ 45% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 399,050

▲ 7% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 153,833

▲ € 118,755 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 1.2 million.

People and assets in 2025

Full-time equivalents

2.6

▲ 1 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 187,125

▲ 77% vs 2024

€ 72,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 34,947

▲ € 30,518 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 18 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 6.6 million

▲ 42% vs 2024

€ 366,806 is repaid this year. At this pace the long-term loan is gone in ≈ 18 years.

Owed to suppliers

€ 50,290

▲ 108% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 48,253

▼ 49% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 262,121 Gross margin 2022: € 262,121 First fiscal year in the series	€ 504,884 Gross margin 2023: € 504,884 ▲ 93% vs 2022 (€ 262,121) Favourable step	€ 450,993 Gross margin 2024: € 450,993 ▼ 11% vs 2023 (€ 504,884) Unfavourable step	€ 434,700 Gross margin 2025: € 434,700 ▼ 4% vs 2024 (€ 450,993) Unfavourable step	▼ 4%
Profit after taxes	€ 164,641 Profit after taxes 2022: € 164,641 First fiscal year in the series	€ 275,558 Profit after taxes 2023: € 275,558 ▲ 67% vs 2022 (€ 164,641) Favourable step	€ 374,598 Profit after taxes 2024: € 374,598 ▲ 36% vs 2023 (€ 275,558) Favourable step	€ 399,050 Profit after taxes 2025: € 399,050 ▲ 7% vs 2024 (€ 374,598) Favourable step	▲ 7%
Equity	€ 239,641 Equity 2022: € 239,641 First fiscal year in the series	€ 515,199 Equity 2023: € 515,199 ▲ 115% vs 2022 (€ 239,641) Favourable step	€ 888,685 Equity 2024: € 888,685 ▲ 72% vs 2023 (€ 515,199) Favourable step	€ 1,285,793 Equity 2025: € 1,285,793 ▲ 45% vs 2024 (€ 888,685) Favourable step	▲ 45%
Total debts	€ 5,089,573 Total debts 2022: € 5,089,573 First fiscal year in the series	€ 5,014,024 Total debts 2023: € 5,014,024 ▼ 1% vs 2022 (€ 5,089,573) Favourable step	€ 4,804,545 Total debts 2024: € 4,804,545 ▼ 4% vs 2023 (€ 5,014,024) Favourable step	€ 6,761,911 Total debts 2025: € 6,761,911 ▲ 41% vs 2024 (€ 4,804,545) Unfavourable step	▲ 41%
Cash	€ 144,867 Cash 2022: € 144,867 First fiscal year in the series	€ 80,509 Cash 2023: € 80,509 ▼ 44% vs 2022 (€ 144,867) Unfavourable step	€ 35,079 Cash 2024: € 35,079 ▼ 56% vs 2023 (€ 80,509) Unfavourable step	€ 153,833 Cash 2025: € 153,833 ▲ € 118,755 vs 2024 (€ 35,079) Favourable step	▲ € 118,755
Retained profit	€ 164,641 Retained profit 2022: € 164,641 First fiscal year in the series	€ 440,199 Retained profit 2023: € 440,199 ▲ 167% vs 2022 (€ 164,641) Favourable step	€ 813,685 Retained profit 2024: € 813,685 ▲ 85% vs 2023 (€ 440,199) Favourable step	€ 1,210,793 Retained profit 2025: € 1,210,793 ▲ 49% vs 2024 (€ 813,685) Favourable step	▲ 49%
Bank debt	€ 5,035,872 Bank debt 2022: € 5,035,872 First fiscal year in the series	€ 4,851,235 Bank debt 2023: € 4,851,235 ▼ 4% vs 2022 (€ 5,035,872) Favourable step	€ 4,664,436 Bank debt 2024: € 4,664,436 ▼ 4% vs 2023 (€ 4,851,235) Favourable step	€ 6,634,202 Bank debt 2025: € 6,634,202 ▲ 42% vs 2024 (€ 4,664,436) Unfavourable step	▲ 42%
Balance sheet total	€ 5,329,214 Balance sheet total 2022: € 5,329,214 First fiscal year in the series	€ 5,529,223 Balance sheet total 2023: € 5,529,223 ▲ 4% vs 2022 (€ 5,329,214) Unchanged	€ 5,693,230 Balance sheet total 2024: € 5,693,230 ▲ 3% vs 2023 (€ 5,529,223) Unchanged	€ 8,047,705 Balance sheet total 2025: € 8,047,705 ▲ 41% vs 2024 (€ 5,693,230) Unchanged	▲ 41%
Employees (FTE)	-	1.2 Employees (FTE) 2023: 1.2 First fiscal year in the series	1.6 Employees (FTE) 2024: 1.6 ▲ 0.4 vs 2023 (1.2) Unchanged	2.6 Employees (FTE) 2025: 2.6 ▲ 1 vs 2024 (1.6) Unchanged	▲ 1

Key figures of met Apotheken, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to met Apotheken?

What happened at met Apotheken in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 22, 2026 New annual accounts for financial year 2025: profit of € 399,050 (▲ 7% vs 2024). Source: NBB ↗
2025 A. Jans Pharma BV became a director. NBB
Feb 18, 2022 New establishment in Bree. KBO
Feb 18, 2022 Start of the company according to the CBE. KBO

In short

From € 164,641 profit in 2022 to € 399,050 profit in 2025.

Paid € 242,205 in corporate taxes since 2022.

Best year ever: 2025, with € 399,050 profit.

On average € 167,200 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Van Dijck-Voets Management BV

A. Jans Pharma BV

Maan Invest BV

Dreesen BV

met Apotheken

Het Apothekershuis 100%

Apotheek Dreesen 100%

Apotheek Janssen 100%

Apotheek Vandijck 100%

Behind met Apotheken are Van Dijck-Voets Management BV, A. Jans Pharma BV, Maan Invest BV and Dreesen BV. It owns 100% of Het Apothekershuis, 100% of Apotheek Dreesen, 100% of Apotheek Janssen and 100% of Apotheek Vandijck itself.

Directors

According to the 2025 annual accounts

Van Dijck-Voets Management BV

Director · represented by Joeri Van Dijck

Also active at: OZOS - Optimale Zorg door Optimale Samenwerking

A. Jans Pharma BV

Director · represented by Andrea Jans

Also active at: Het Apothekershuis

since 2025

Maan Invest BV

Director · represented by Ben Janssen

Dreesen BV

Director · represented by Francesca Dreesen

Establishments

Establishment units

Physical locations of this company

Registered office

Witte Torenwal 41

3960 Bree

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Apotheek VAN DIJCK same network

€ 306,728 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0782.370.920

VAT number

BE 0782.370.920

Registered office

Witte Torenwal 41, 3960 Bree

Names & denominations

met Apotheken

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

18 February 2022

Peppol

Active · Active since 24 Nov 2023

Activities · NACE

Detailhandel in farmaceutische producten

Activiteiten van holdings

Holdings

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige ondersteunende activiteiten in verband met financiële diensten, neg, exclusief verzekeringen en pensioenfondsen

Overige zakelijke dienstverlening, neg

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

View on CBE Public ↗ Annual accounts (NBB) ↗

met Apotheken

Financials

What happened to met Apotheken?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions